ACM meeting #23, 1-2 October 2020

The meeting of the Advisory Committee on Medicines (ACM).

The committee’s advice was sought on 8 applications under evaluation by the TGA. The applications included:

• one for the registration of a new chemical entity
• one for the registration of a new biological entity
• three seeking extension of indications
• three seeking major variations (change in dose form, route of administration and/or new strength)

Members

Membership comprises of professionals with specific scientific, medical or clinical expertise, as well as appropriate consumer health issues relating to medicines.